Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study
Authors
Keywords
-
Journal
BIOLOGICAL PSYCHIATRY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-09-06
DOI
10.1016/j.biopsych.2022.08.025
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants
- (2022) Felix Müller et al. PSYCHOPHARMACOLOGY
- Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
- (2022) Friederike Holze et al. NEUROPSYCHOPHARMACOLOGY
- Trial of Psilocybin versus Escitalopram for Depression
- (2021) Robin Carhart-Harris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety pharmacology of acute LSD administration in healthy subjects
- (2021) Friederike Holze et al. PSYCHOPHARMACOLOGY
- Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?
- (2021) Rita Kočárová et al. Frontiers in Psychiatry
- Acute subjective effects in LSD- and MDMA-assisted psychotherapy
- (2020) Yasmin Schmid et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
- (2020) Friederike Holze et al. NEUROPSYCHOPHARMACOLOGY
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- (2020) Alan K. Davis et al. JAMA Psychiatry
- Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects
- (2019) Friederike Holze et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
- (2018) Leor Roseman et al. Frontiers in Pharmacology
- Long-lasting subjective effects of LSD in normal subjects
- (2017) Yasmin Schmid et al. PSYCHOPHARMACOLOGY
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
- (2015) Yasmin Schmid et al. BIOLOGICAL PSYCHIATRY
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
- (2014) Peter Gasser et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
- (2014) Peter Gasser et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies
- (2011) Alex J Mitchell et al. LANCET ONCOLOGY
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
- (2010) Charles S. Grob et al. ARCHIVES OF GENERAL PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started